- Home
- GETY vs OCS Comparison
GETY vs OCS Comparison
Compare GETY & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GETY
- OCS
- Stock Information
- Founded
- GETY 1995
- OCS 2003
- Country
- GETY United States
- OCS Switzerland
- Employees
- GETY N/A
- OCS N/A
- Industry
- GETY Industrial Machinery/Components
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- GETY Industrials
- OCS Health Care
- Exchange
- GETY Nasdaq
- OCS Nasdaq
- Market Cap
- GETY 867.0M
- OCS 1.0B
- IPO Year
- GETY N/A
- OCS N/A
- Fundamental
- Price
- GETY $1.45
- OCS $19.21
- Analyst Decision
- GETY Hold
- OCS Strong Buy
- Analyst Count
- GETY 6
- OCS 5
- Target Price
- GETY $4.76
- OCS $39.80
- AVG Volume (30 Days)
- GETY 8.6M
- OCS 115.6K
- Earning Date
- GETY 11-10-2025
- OCS 11-10-2025
- Dividend Yield
- GETY N/A
- OCS N/A
- EPS Growth
- GETY N/A
- OCS N/A
- EPS
- GETY N/A
- OCS N/A
- Revenue
- GETY $946,327,000.00
- OCS $991,999.00
- Revenue This Year
- GETY $2.35
- OCS $32.89
- Revenue Next Year
- GETY $3.07
- OCS $1,043.16
- P/E Ratio
- GETY N/A
- OCS N/A
- Revenue Growth
- GETY 3.10
- OCS N/A
- 52 Week Low
- GETY $1.25
- OCS $14.00
- 52 Week High
- GETY $3.87
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- GETY 28.25
- OCS 45.64
- Support Level
- GETY $1.42
- OCS $19.01
- Resistance Level
- GETY $1.55
- OCS $19.87
- Average True Range (ATR)
- GETY 0.23
- OCS 0.57
- MACD
- GETY -0.04
- OCS -0.11
- Stochastic Oscillator
- GETY 1.15
- OCS 23.04
About GETY Getty Images Holdings Inc.
Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.